CTLA4 and Crohn disease: CTLA-4 inhibition disrupts mucosal self-tolerance by depleting regulatory T-cells in the gut, and genetic factors like CTLA-4 polymorphisms may increase the risk of early-onset Crohn’s disease [25,26].